BioSpecifics Technologies Competitors and Similar CompaniesClear all
BioSpecifics Technologies's competitors and similar companies include WuXi AppTec, Prevail Therapeutics, Molecular Partners and Acousia Therapeutics.
 BioSpecifics Technologies BioSpecifics Technologies is a biopharmaceutical company that has developed injectable collagenase for different clinical indications. |  WuXi AppTec WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production. |  Prevail Therapeutics Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease. |  Molecular Partners Molecular Partners is a company that develops biopharmaceutical products for serious diseases. |  Acousia Therapeutics Acousia Therapeutics is a biotech company working to identify small molecules for treatment of hearing loss. | |
Founding Date | Founding Date 1957 | Founding Date 2000 | Founding Date 2017 | Founding Date 2004 | Founding Date 2017 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Lynbrook, US HQ Wilmington, US | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Nanjing, CN Nantong, CN Shanghai, CN see more | Locations New York, US HQ | Locations Zürich-Schlieren, CH HQ Cambridge, US Concord, US | Locations Tübingen, DE HQ |
Employees | Employees 740% increase | Employees 39,414 | Employees 489% increase | Employees 158 | Employees N/A |
Valuation ($) | Valuation ($) 650.2 m | Valuation ($) 20.7 b | Valuation ($) 787.7 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $38.2m (FY, 2019) | Revenue (est.) ¥43.1b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ¥23.8b (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ¥21.3b (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income $24.5m (FY, 2019) | Net income ¥19.3b (FY, 2025) | Net income ($63.2m) (FY, 2019) | Net income (CHF61.7m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 902.6m | Total funding raised $ 125m | Total funding raised N/A | Total funding raised $ 14.6m |
For sources of this data, please see the company profile
View Company Profiles
WuXi AppTec
HQ
Shanghai, CN
Employees
39,414
WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production.
View companyPrevail Therapeutics
HQ
New York, US
Employees
48↑ 9% increase
Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease.
View companyMolecular Partners
HQ
Zürich-Schlieren, CH
Employees
158
Molecular Partners is a company that develops biopharmaceutical products for serious diseases.
View companyAcousia Therapeutics
HQ
Tübingen, DE
Acousia Therapeutics is a biotech company working to identify small molecules for treatment of hearing loss.
View company